Regeneron’s Inmazeb gets FDA approval for Ebola treatment
This article was originally published here
Inmazeb, which was previously called REGN-EB3, is now the first treatment to have been approved by the FDA for Ebola. The antibody cocktail has been indicated for the
The post Regeneron’s Inmazeb gets FDA approval for Ebola treatment appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!